Flanagan W. Michael
Chief Scientific Officer
CIK: 1841990
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 150,365 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 88,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 50,000 | - | - | View Details Filing |
| Feb 27, 2026 | Atrium Therapeutics, Inc. (RNA) | A | 20,000 | $0.00 | $0.00 | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 25,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 66,500 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 96,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 72,000 | - | - | View Details Filing |
| Jan 21, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 2,558 | $72.45 | $185,327.10 | View Details Filing |
| Jan 21, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 3,976 | $72.45 | $288,061.20 | View Details Filing |
| Jan 7, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 2,373 | $72.23 | $171,401.79 | View Details Filing |